{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:59:25Z","timestamp":1778047165036,"version":"3.51.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Individuals living with HIV are at increased risk of developing cardiovascular diseases. This heightened vulnerability is influenced by various factors, including the direct impact of HIV infection, the side effects of HIV medications, and a higher presence of traditional cardiovascular risk factors. Detecting and managing cardiovascular diseases early in HIV-infected individuals is crucial for their overall health and well-being. Electrocardiography, a simple and non-invasive test, can provide valuable information in this regard. However, there is currently no published data on the prevalence of electrocardiographic abnormalities and the associated factors among HIV-infected adults in Ethiopia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study was aimed at assessing the prevalence of ECG abnormalities and associated factors among HIV-infected adults on antiretroviral therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>A hospital-based comparative cross-sectional study was conducted at Mettu Karl Specialized Hospital (MKSH), southwest Ethiopia, among 96 HIV-infected patients and 96 HIV-negative control groups. A systematic random sampling technique was used to select HIV-infected respondents, and HIV-negative respondents were purposively recruited from caregivers. A face-to-face interview with a semi-structured and pretested questionnaire was conducted to collect the socio-demographic and behavioral characteristics of the study participants. Electrocardiography was done for all study participants using a 12-lead electrocardiograph, interpreted by a cardiologist, and classified according to the Minnesota Code classification system. The data were entered into Epi-Data version 4.6 and exported to SPSS version 25 for analysis. Finally, descriptive statistics, chi-square, independent <jats:italic>t<\/jats:italic>-test, bivariable, and multivariable logistic regression analyses were done at a 5% significance level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study found that 49% of HIV-infected and 19.8% of HIV-negative participants had at least one ECG abnormality. The proportion of coded ST-segment abnormalities, T-wave abnormalities, longer QT interval, and sinus tachycardia was significantly higher in HIV-infected respondents than in HIV-negatives. Being a smoker [AOR\u2009=\u20093.7, 95%CI: 1.03\u201313.6], being on Protease inhibitors [AOR\u2009=\u20093.6, 95%CI: 1.02\u201313.1] and having CD4 less than 350\u2005cells\/mm<jats:sup>3<\/jats:sup> [AOR\u2009=\u20093.2, 95%CI: 1.22\u20138.49] were significantly associated with ECG abnormalities among HIV-infected respondents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Compared to HIV-negative participants, HIV-infected patients had a significantly higher prevalence of ECG abnormalities. Screening for ECG abnormalities is needed for the early detection of cardiac abnormalities and the reduction of future complications.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frph.2024.1387464","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T05:12:50Z","timestamp":1725945170000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Electrocardiographic abnormalities and associated factors among HIV-infected adults on antiretroviral therapy"],"prefix":"10.3389","volume":"6","author":[{"given":"Zewudu","family":"Befkadu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanuel","family":"Tadelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsah","family":"Tegene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4066\/2591-7951.1000051","article-title":"Cardiovascular manifestations of HIV infection: a review","volume":"2","author":"Kumar","year":"2018","journal-title":"Arch Gen Intern Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/jgid.jgid_4_18","article-title":"Cardiovascular disease and antiretroviral therapy","volume":"11","author":"Jarwani","year":"2019","journal-title":"J Glob Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","article-title":"HIV and cardiovascular disease","volume":"7","author":"So-Armah","year":"2020","journal-title":"Lancet HIV"},{"key":"B4","first-page":"395","article-title":"Complications of HIV infection: a systems-based approach","volume":"83","author":"Chu","year":"2011","journal-title":"Am Fam Physician"},{"key":"B5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/openhrt-2014-000174","article-title":"Cardiovascular disease in HIV patients: from bench to bedside and backwards","volume":"2","author":"Cerrato","year":"2015","journal-title":"Open Hear"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","article-title":"Sudden cardiac death in patients with human immunodeficiency virus infection","volume":"59","author":"Tseng","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","article-title":"Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013","volume":"117","author":"Feinstein","year":"2016","journal-title":"Am J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/QAD.0000000000001109","article-title":"Inflammation, immune activation, and cardiovascular disease in HIV","volume":"176","author":"Nou","year":"2016","journal-title":"Physiol Behav"},{"key":"B10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2016","journal-title":"JAMA Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bmjopen-2018-025874","article-title":"Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis","volume":"9","author":"Eyawo","year":"2019","journal-title":"BMJ Open"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000025236","article-title":"Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: prevalence and associated factors","volume":"100","author":"Hamooya","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.dsx.2014.04.008","article-title":"Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia","volume":"8","author":"Tesfaye","year":"2014","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/00002030-200409030-00010","article-title":"Cardio- and cerebrovascular events in HIV-infected persons","volume":"18","author":"Monforte A","year":"2004","journal-title":"Aids"},{"key":"B15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacc.2018.04.083","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure","volume":"72","author":"Alvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbadis.2013.11.019","article-title":"HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system","volume":"1842","author":"Reyskens","year":"2014","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/aps.2014.165","article-title":"The protease inhibitor atazanavir blocks hERG K+ channels expressed in HEK293 cells and obstructs hERG protein transport to cell membrane","volume":"36","author":"Han","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B19","first-page":"81","article-title":"Study of electrocardiographic and echocardiographic abnormalities in HIV positive patient with special reference to CD4 count","volume":"4","author":"Singh","year":"2021","journal-title":"Int J Heal Clin Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ihj.2019.09.006","article-title":"Cardiovascular manifestations of people living with HIV\/AIDS: report from a hot spot in eastern India","volume":"71","author":"Mishra","year":"2019","journal-title":"Indian Heart J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/bst.2020.01013","article-title":"Electrocardiographic abnormalities among people with HIV in Shanghai, China","volume":"14","author":"Shen","year":"2020","journal-title":"Biosci Trends Adv Publ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.55320\/mjz.43.1.307","article-title":"Prevalence of subclinical cardiovascular disease in healthy HIV infected patients at the university teaching hospital in Lusaka, Zambia","volume":"43","author":"Kabwe","year":"2016","journal-title":"Med J Zambia"},{"key":"B23","volume-title":"Electrocardiographic Abnormalities among HIV Infected Adults Attending the Comprehensive Care Center at Kenyatta Nationa Hospital, a Dessertation Submitted in Partial Fulfillement the Award of Master of Medicine in Internal Medicine","author":"Cimpaye","year":"2018"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/clc.23273","article-title":"Cardiovascular risk factors among Ghanaian patients with HIV: a cross-sectional study","volume":"42","author":"Appiah","year":"2019","journal-title":"Clin Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4103\/1119-3077.208954","article-title":"Structural echocardiographic abnormalities seen in HIV\/AIDS patients are independent of CD4 count","volume":"20","author":"Ogunmodede","year":"2017","journal-title":"Niger J Clin Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5830\/CVJA-2016-007","article-title":"Electrocardiographic findings in a cross-sectional study of human immunodeficiency virus (HIV) patients in Enugu, South-East Nigeria","volume":"27","author":"Njoku","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jelectrocard.2010.10.027","article-title":"Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the strategies for management of antiretroviral therapy (SMART) study","volume":"44","author":"Soliman","year":"2012","journal-title":"J Electrocardiol"},{"key":"B28","first-page":"1","volume-title":"HIV and AIDS Estimates of Adults and Children Living in Ethiopia\/2019","year":"2019"},{"key":"B29","first-page":"1","volume-title":"Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities","year":"2007"},{"key":"B30","first-page":"1","volume-title":"The Minnesota Code Manual of Electrocardiographic Findings Standards and Procedures for ECG Measurement in Epidemiologic and Clinical Trials","author":"Prineas","year":"2010"},{"key":"B31","volume-title":"American Heart Association Recommendations for Physical Activity in Adults and Kids","year":"2020"},{"key":"B32","first-page":"24","article-title":"A study of cardiovascular abnormalities in HIV positive patients in a tertiary care hospital in Northern India","volume":"65","author":"Chaudhary","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"B33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5830\/CVJA-2017-013","article-title":"Electrocardiographic abnormalities in treatment-na\u00efve HIV subjects in South-East Nigeria","volume":"28","author":"Okoye","year":"2017","journal-title":"Cardiovasc J Afr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.21037\/cdt.2017.10.12","article-title":"Echocardiographic and electrocardiographic abnormalities in adults living with human immunodeficiency virus: a cross- sectional study in the Yaound\u00e9 Central Hospital, Cameroon","volume":"7","author":"Hamadou","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"B35","first-page":"1220","article-title":"Evaluation of ECG abnormalities in HIV infected patients in urban part of south India","volume":"2","author":"Sakthivadivel","year":"2014","journal-title":"Sch J Appl Med Sci (SJAMS)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1689.e1","DOI":"10.1016\/j.cmi.2020.03.005","article-title":"HIV infection and electrocardiogram abnormalities: baseline assessment from the CHART cohort","volume":"26","author":"Ding","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1475-097X.2007.00760.x","article-title":"Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability","volume":"27","author":"Lebech","year":"2007","journal-title":"Clin Physiol Funct Imaging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1097\/QAD.0b013e328360e9fb","article-title":"Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression","volume":"27","author":"Graham","year":"2013","journal-title":"Aids"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbih.2020.100112","article-title":"Sympathetic function and markers of inflammation in well-controlled HIV","volume":"7","author":"Robinson-Papp","year":"2020","journal-title":"Brain Behav Immun Heal"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyg.2017.00213","article-title":"Heart rate variability and cardiac vagal tone in psychophysiological research\u2014recommendations for experiment planning, data analysis, and data reporting","volume":"8","author":"Laborde","year":"2017","journal-title":"Front Psychol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/s21051906","article-title":"Detection of myocardial infarction using ECG and multi-scale feature concatenate","volume":"21","author":"Jian","year":"2021","journal-title":"Sensors"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14386","DOI":"10.1073\/pnas.212327899","article-title":"Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways","volume":"99","author":"Twu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/anec.12162","article-title":"QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.pdf","volume":"16","author":"Wongcharoen","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-017-1053-9","article-title":"Prolongation of the QTc interval in HIV\u2014infected individuals compared to the general population","volume":"45","author":"Reinsch","year":"2017","journal-title":"Infection"},{"key":"B45","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.yjmcc.2011.07.017","article-title":"HIV Tat protein inhibits hERG K+channels: a potential mechanism of HIV infection induced LQTs","volume":"51","author":"Bai","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2021.704106","article-title":"Smoking and the pathophysiology of peripheral artery disease","volume":"8","author":"Wang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.7860\/JCDR\/2013\/5180.2950","article-title":"ECG changes in smokers and non smokers-A comparative study","volume":"7","author":"Renuka Devi","year":"2013","journal-title":"J Clin Diagnostic Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1097\/QAD.0000000000002327","article-title":"Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV","volume":"33","author":"Dehlb\u00e6k","year":"2019","journal-title":"Wolters Kluwer Heal"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2024.1387464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T05:12:58Z","timestamp":1725945178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2024.1387464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":49,"alternative-id":["10.3389\/frph.2024.1387464"],"URL":"https:\/\/doi.org\/10.3389\/frph.2024.1387464","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"article-number":"1387464"}}